MoonLake Immunotherapeutics ($MLTX)
Filing Information
| Accession Number | 0001213900-26-043647 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 14, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
150,000
Total Value
$2,752,162.86
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Class A ordinary shares, par value $0.0001 per share | โ | Apr 10, 2026 | Sale | 98,127 | $18.41 | $1,806,518.07 | 2,976,766 | Direct | โ | View Details | |
Director | Class A ordinary shares, par value $0.0001 per share | โ | Apr 13, 2026 | Sale | 51,873 | $18.23 | $945,644.79 | 2,924,893 | Direct | โ | View Details |